# 2025-16720: DOT Adds Fentanyl to Workplace Drug Testing Panel

2025-16720, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Fentanyl to the Department of Transportation's Drug-Testing Panel; Harmonization With Certain Items in the HHS Mandatory Guidelines for Urine and Oral Fluid; and Technical Amendments, is a Federal Register proposed rule from Transportation Department published 2025-09-02 (as of 2026-06-11).

- Canonical: https://policyrisk.com/federal-register/2025-16720
- As of: 2026-06-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-16720
- Title: Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Fentanyl to the Department of Transportation's Drug-Testing Panel; Harmonization With Certain Items in the HHS Mandatory Guidelines for Urine and Oral Fluid; and Technical Amendments
- Type: Proposed Rule
- Agencies: Transportation Department
- Citation: 90 FR 42363
- Published: 2025-09-02
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: 2105-AF26
- Last updated: 2026-06-11

## In one line

DOT Adds Fentanyl to Workplace Drug Testing Panel

## Summary

The Department of Transportation is updating its drug testing rules to include fentanyl, a powerful opioid, to keep transportation safer. This change affects drivers and workers in transportation jobs and aligns DOT rules with health guidelines. The update also fixes some technical details and will roll out soon, helping catch drug use more accurately without extra costs.

## Abstract

The U.S. Department of Transportation (Department or DOT) proposes to amend its drug-testing program regulation, 49 CFR part 40 (part 40), to add fentanyl (a synthetic opioid) and norfentanyl (a metabolite of fentanyl) to its drug testing panels. The proposed rulemaking would harmonize part 40 with the U.S. Department of Health and Human Services (HHS) Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines), which DOT must follow for the minimum list of drugs for which DOT requires testing, and the comprehensive standards for laboratory drug testing per the Omnibus Employee Testing Act of 1991. Adding fentanyl and norfentanyl is also in the interest of transportation safety, given compelling information regarding the number of overdose deaths in the United States involving fentanyl. The Department also proposes to amend certain provisions of part 40 to harmonize, as appropriate, with the current HHS Mandatory Guidelines using urine (UrMG) and oral fluid (OFMG). This NPRM also proposes to clarify certain existing part 40 drug testing program provisions and to make technical amendments.

## Effects PRIA read

- Fentanyl Added to DOT Drug Panel: benefit, medium. The Department of Transportation proposes to add fentanyl (a synthetic opioid) and norfentanyl (its metabolite) to the list of drugs for which DOT requires testing. If you work in transportation and are subject to DOT drug testing, you may be tested for fentanyl and norfentanyl under these proposed…
- Harmonize Testing with HHS Urine/Oral Guidelines: benefit, low. DOT proposes to amend 49 CFR part 40 to harmonize its drug-testing rules with the HHS Mandatory Guidelines for urine (UrMG) and oral fluid (OFMG) testing and to update laboratory testing standards. These changes would align DOT procedures with HHS standards and clarify certain existing part 40 prog…

## Related documents

- [2026-22617](https://policyrisk.com/federal-register/2026-22617): Deepwater Port Application Processing and Licensing, 2026-11-05
- [2026-22396](https://policyrisk.com/federal-register/2026-22396): Pipeline Safety: Amendments to Liquefied Natural Gas Facilities, 2026-11-03
- [2026-21794](https://policyrisk.com/federal-register/2026-21794): Federal Motor Vehicle Safety Standards; Modernization of FMVSS No. 108 To Accommodate ADS-Equipped Vehicles, 2026-10-26
- [2026-21058](https://policyrisk.com/federal-register/2026-21058): Cause of Airline Delay and Cancellation Categories Under Section 511(b) of the FAA Reauthorization Act of 2024; Delay of Effective Date, 2026-10-15
- [2026-19964](https://policyrisk.com/federal-register/2026-19964): The Safer Affordable Fuel-Efficient (SAFE) Vehicles Rule III for Model Years 2022 to 2031 Passenger Cars and Light Trucks, 2026-09-30
- [2026-18040](https://policyrisk.com/federal-register/2026-18040): Cause of Airline Delay and Cancellation Categories Under Section 511(b) of the FAA Reauthorization Act of 2024, 2026-09-03

## Sources
- [2025-16720 on federalregister.gov](https://www.federalregister.gov/documents/2025/09/02/2025-16720/procedures-for-transportation-workplace-drug-and-alcohol-testing-programs-addition-of-fentanyl-to)
- [2025-16720 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-09-02/pdf/2025-16720.pdf)

## Related
- [Previous: 2025-16688, Endangered and Threatened Wildlife and Plants; Threatened Species Status With S…](https://policyrisk.com/federal-register/2025-16688)
- [Next: 2025-16723, Air Plan Approval; GA; Removal of Nonattainment Area New Source Review](https://policyrisk.com/federal-register/2025-16723)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-16720 (as of 2026-06-11).
